TheraVasc

BiotechnologySeries ACleveland, UStheravasc.com

Latest round

Series A

Last raised

Sep 2010

Total raised

$2.3M

Investors

5

About TheraVasc

TheraVasc is based in US and operates as a biotechnology company, develops vascular therapies through the repositioning of drugs for the treatment of vascular disorders.

Who invested in TheraVasc

5 investors across 2 rounds

See all investors in TheraVasc

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Sep 27, 2010

    Amount

    $1.8M

    Investors

    Locked

  2. Seed

    Jan 6, 2010

    Amount

    $0.5M

    Investors

    Locked

Questions about TheraVasc

Who invested in TheraVasc?

TheraVasc has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has TheraVasc raised?

TheraVasc has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did TheraVasc last raise money?

TheraVasc's most recent round on record is a Series A, in Sep 2010.

What does TheraVasc do?

TheraVasc is based in US and operates as a biotechnology company, develops vascular therapies through the repositioning of drugs for the treatment of vascular disorders.

Where is TheraVasc headquartered?

TheraVasc is headquartered in Cleveland, US.

Which VCs invest in companies like TheraVasc?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at TheraVasc's stage. Their profiles are linked below.

Raising like TheraVasc? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.